SHARE
Intranasal Drug And Vaccine Delivery Market

Intranasal Drug and Vaccine Delivery - Global Market Outlook (2019 -2027)

4.7 (87 reviews)
Published: August 2020 ID: SMRC19820
4.7 (87 reviews)
Published: August 2020 ID: SMRC19820

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Intranasal Drug and Vaccine Delivery Market is accounted for $46.20 billion in 2019 and is expected to reach $88.75 billion by 2027 growing at a CAGR of 8.5% during the forecast period. Growing preference for nasal products, increasing prevalence of respiratory and neurological diseases, and surge in intranasal product launches are the major factors propelling the market growth. However, moderate complications and side effects associated with the use of nasal products are hampering the market growth.

Drug delivery refers to a process of delivering a drug into the patient’s body to have an effective therapeutic effect. Different modes are used for the delivery of drug. Nasal and pulmonary routes are most popular modes for delivering drug. The global drug delivery market is growing at a significant rate due to growing awareness in the field and technical innovations in the field. Intranasal drug delivery refers to a process of delivering the administered drug through nasal route. Drugs that are delivering through nasal means may be prescribed for acute or chronic treatments. Various types of drugs that are delivered through nasal cavity are local anaesthetics, antibiotics, pain relief drugs, calcium supplements, vasoconstrictors, snuffs, antihistamines and others.

Based on the distribution channel, the online pharmacies segment is going to have a lucrative growth during the forecast period due to the discounts offered, as well as cost-effectiveness to patients and payers in the long run. Moreover, increasing inclination towards online purchases has brought advantages to the online pharmacies segment.

By geography, Asia Pacific is going to have a lucrative growth during the forecast period due to the increasing product development protocols, economic growth, and increase in the number of local market players involved in the development of novel drug delivery systems. China and India are expected to be the fastest growing intranasal drug delivery markets in Asian region. This is due to large investment by various major companies in these countries. Some of the key driving forces for intranasal drug delivery market in emerging countries are large pool of patients, rising government funding and improvement in the healthcare facilities.

Some of the key players profiled in the Intranasal Drug and Vaccine Delivery Market include 3M, Aptar Pharma, Bespak, GlaxoSmithKline Plc, Intersect ENT, OptiNose, Inc., Teleflex Corporation, Teva Pharmaceuticals, and UCB, Inc.

Products Covered:
• Liquid Delivery Device
• Powder Delivery Device
• Pressurized Metered Dose Inhaler

Dosages Covered:
• Multi-Dose
• Unit-Dose

Applications Covered:
• Neurological Disorder
• Pain Management
• Respiratory Disorders
• Vaccination

Distribution Channels Covered:
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019 2020, 2024, and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary          
           
2 Preface  
       
 2.1 Abstract         
 2.2 Stake Holders         
 2.3 Research Scope         
 2.4 Research Methodology         
  2.4.1 Data Mining        
  2.4.2 Data Analysis        
  2.4.3 Data Validation        
  2.4.4 Research Approach        
 2.5 Research Sources         
  2.5.1 Primary Research Sources        
  2.5.2 Secondary Research Sources        
  2.5.3 Assumptions        
           
3 Market Trend Analysis          
 3.1 Introduction         
 3.2 Drivers         
 3.3 Restraints         
 3.4 Opportunities         
 3.5 Threats         
 3.6 Product Analysis         
 3.7 Application Analysis         
 3.8 Emerging Markets         
 3.9 Impact of Covid-19         
           
4 Porters Five Force Analysis          
 4.1 Bargaining power of suppliers         
 4.2 Bargaining power of buyers         
 4.3 Threat of substitutes         
 4.4 Threat of new entrants         
 4.5 Competitive rivalry         
           
5 Global Intranasal Drug and Vaccine Delivery Market, By Product          
 5.1 Introduction         
 5.2 Liquid Delivery Device         
 5.3 Powder Delivery Device         
 5.4 Pressurized Metered Dose Inhaler         
           
6 Global Intranasal Drug and Vaccine Delivery Market, By Dosage          
 6.1 Introduction         
 6.2 Multi-Dose         
 6.3 Unit-Dose         
           
7 Global Intranasal Drug and Vaccine Delivery Market, By Application          
 7.1 Introduction         
 7.2 Neurological Disorder         
 7.3 Pain Management         
 7.4 Respiratory Disorders         
 7.5 Vaccination         
           
8 Global Intranasal Drug and Vaccine Delivery Market, By Distribution Channel          
 8.1 Introduction         
 8.2 Hospital Pharmacies         
 8.3 Online Pharmacies         
 8.4 Retail Pharmacies         
           
9 Global Intranasal Drug and Vaccine Delivery Market, By Geography          
 9.1 Introduction         
 9.2 North America         
  9.2.1 US        
  9.2.2 Canada        
  9.2.3 Mexico        
 9.3 Europe         
  9.3.1 Germany        
  9.3.2 UK        
  9.3.3 Italy        
  9.3.4 France        
  9.3.5 Spain        
  9.3.6 Rest of Europe        
 9.4 Asia Pacific         
  9.4.1 Japan        
  9.4.2 China        
  9.4.3 India        
  9.4.4 Australia        
  9.4.5 New Zealand        
  9.4.6 South Korea        
  9.4.7 Rest of Asia Pacific        
 9.5 South America         
  9.5.1 Argentina        
  9.5.2 Brazil        
  9.5.3 Chile        
  9.5.4 Rest of South America        
 9.6 Middle East & Africa         
  9.6.1 Saudi Arabia        
  9.6.2 UAE        
  9.6.3 Qatar        
  9.6.4 South Africa        
  9.6.5 Rest of Middle East & Africa        
           
10 Key Developments          
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures         
 10.2 Acquisitions & Mergers         
 10.3 New Product Launch         
 10.4 Expansions         
 10.5 Other Key Strategies         
           
11 Company Profiling          
 11.1 3M         
 11.2 Aptar Pharma         
 11.3 Bespak         
 11.4 GlaxoSmithKline Plc         
 11.5 Intersect ENT         
 11.6 OptiNose, Inc.         
 11.7 Teleflex Corporation         
 11.8 Teva Pharmaceuticals         
 11.9 UCB, Inc


List of Tables           
1 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Region (2018-2027) ($MN)          
2 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Product (2018-2027) ($MN)          
3 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Liquid Delivery Device (2018-2027) ($MN)          
4 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Powder Delivery Device (2018-2027) ($MN)          
5 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Pressurized Metered Dose Inhaler (2018-2027) ($MN)          
6 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Dosage (2018-2027) ($MN)          
7 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Multi-Dose (2018-2027) ($MN)          
8 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Unit-Dose (2018-2027) ($MN)          
9 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Application (2018-2027) ($MN)          
10 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Neurological Disorder (2018-2027) ($MN)          
11 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Pain Management (2018-2027) ($MN)          
12 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Respiratory Disorders (2018-2027) ($MN)          
13 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Vaccination (2018-2027) ($MN)          
14 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Distribution Channel (2018-2027) ($MN)          
15 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)          
16 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Online Pharmacies (2018-2027) ($MN)          
17 Global Intranasal Drug and Vaccine Delivery Market Outlook, By Retail Pharmacies (2018-2027) ($MN)          
18 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Country (2018-2027) ($MN)          
19 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Product (2018-2027) ($MN)          
20 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Liquid Delivery Device (2018-2027) ($MN)
21 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Powder Delivery Device (2018-2027) ($MN)          
22 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Pressurized Metered Dose Inhaler (2018-2027) ($MN)          
23 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Dosage (2018-2027) ($MN)          
24 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Multi-Dose (2018-2027) ($MN)          
25 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Unit-Dose (2018-2027) ($MN)          
26 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Application (2018-2027) ($MN)          
27 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Neurological Disorder (2018-2027) ($MN)
28 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Pain Management (2018-2027) ($MN)
29 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Respiratory Disorders (2018-2027) ($MN)
30 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Vaccination (2018-2027) ($MN)          
31 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Distribution Channel (2018-2027) ($MN)
32 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
33 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Online Pharmacies (2018-2027) ($MN)
34 North America Intranasal Drug and Vaccine Delivery Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
35 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Country (2018-2027) ($MN)          
36 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Product (2018-2027) ($MN)          
37 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Liquid Delivery Device (2018-2027) ($MN)          
38 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Powder Delivery Device (2018-2027) ($MN)
39 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Pressurized Metered Dose Inhaler (2018-2027) ($MN)          
40 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Dosage (2018-2027) ($MN)          
41 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Multi-Dose (2018-2027) ($MN)          
42 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Unit-Dose (2018-2027) ($MN)          
43 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Application (2018-2027) ($MN)          
44 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Neurological Disorder (2018-2027) ($MN)          
45 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Pain Management (2018-2027) ($MN)          
46 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Respiratory Disorders (2018-2027) ($MN)          
47 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Vaccination (2018-2027) ($MN)          
48 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Distribution Channel (2018-2027) ($MN)          
49 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)          
50 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Online Pharmacies (2018-2027) ($MN)          
51 Europe Intranasal Drug and Vaccine Delivery Market Outlook, By Retail Pharmacies (2018-2027) ($MN)          
52 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Country (2018-2027) ($MN)          
53 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Product (2018-2027) ($MN)          
54 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Liquid Delivery Device (2018-2027) ($MN)
55 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Powder Delivery Device (2018-2027) ($MN)
56 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Pressurized Metered Dose Inhaler (2018-2027) ($MN)          
57 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Dosage (2018-2027) ($MN)          
58 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Multi-Dose (2018-2027) ($MN)          
59 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Unit-Dose (2018-2027) ($MN)          
60 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Application (2018-2027) ($MN)          
61 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Neurological Disorder (2018-2027) ($MN)
62 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Pain Management (2018-2027) ($MN)          
63 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Respiratory Disorders (2018-2027) ($MN)
64 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Vaccination (2018-2027) ($MN)          
65 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Distribution Channel (2018-2027) ($MN)
66 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
67 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Online Pharmacies (2018-2027) ($MN)
68 Asia Pacific Intranasal Drug and Vaccine Delivery Market Outlook, By Retail Pharmacies (2018-2027) ($MN)          
69 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Country (2018-2027) ($MN)          
70 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Product (2018-2027) ($MN)          
71 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Liquid Delivery Device (2018-2027) ($MN)          
72 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Powder Delivery Device (2018-2027) ($MN)          
73 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Pressurized Metered Dose Inhaler (2018-2027) ($MN)          
74 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Dosage (2018-2027) ($MN)          
75 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Multi-Dose (2018-2027) ($MN)          
76 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Unit-Dose (2018-2027) ($MN)          
77 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Application (2018-2027) ($MN)          
78 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Neurological Disorder (2018-2027) ($MN)
79 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Pain Management (2018-2027) ($MN)
80 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Respiratory Disorders (2018-2027) ($MN)
81 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Vaccination (2018-2027) ($MN)          
82 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Distribution Channel (2018-2027) ($MN)
83 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
84 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Online Pharmacies (2018-2027) ($MN)
85 South America Intranasal Drug and Vaccine Delivery Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
86 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Country (2018-2027) ($MN)          
87 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Product (2018-2027) ($MN)          
88 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Liquid Delivery Device (2018-2027) ($MN)          
89 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Powder Delivery Device (2018-2027) ($MN)          
90 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Pressurized Metered Dose Inhaler (2018-2027) ($MN)          
91 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Dosage (2018-2027) ($MN)          
92 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Multi-Dose (2018-2027) ($MN)
93 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Unit-Dose (2018-2027) ($MN)          
94 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Application (2018-2027) ($MN)
95 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Neurological Disorder (2018-2027) ($MN)          
96 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Pain Management (2018-2027) ($MN)          
97 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Respiratory Disorders (2018-2027) ($MN)          
98 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Vaccination (2018-2027) ($MN)
99 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Distribution Channel (2018-2027) ($MN)          
100 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)          
101 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Online Pharmacies (2018-2027) ($MN)          
102 Middle East & Africa Intranasal Drug and Vaccine Delivery Market Outlook, By Retail Pharmacies (2018-2027) ($MN)

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials